Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
12-03-01 Drugs for oral ulceration and inflammation
In East Lancashire| Carmellose Sodium Orabase® |
|
Formulary
|
| Protective paste carmellose 16.7%, pectin 16.7%, gelatin 16.7% in Plastibase® |
|
| Hydrocortisone Corlan® |
|
Formulary
|
| Pellets 2.5mg |
 MHRA: Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks |
|
|
Links
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA Drug Safety Update Dec 2018: Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks
- MHRA Drug Safety Update Dec 2018: Oral lidocaine-containing products for infant teething: only to be available under the supervision of a pharmacist
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people